Kentucky Retirement Systems Biogen Inc. Transaction History

Kentucky Retirement Systems

$3.42 Billion
Q2 2024

A detailed history of Kentucky Retirement Systems transactions in Biogen Inc. stock. As of the latest transaction made, Kentucky Retirement Systems holds 10,972 shares of BIIB stock, worth $1.91 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares

10,972

Previous 11,004 0.29%

Holding current value

$1.91 Million

Previous $2.37 Million 7.21%

% of portfolio

0.07%

Previous 0.07%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	SELL	$190.52 - $236.72 $6,096 - $7,575	-32 Reduced 0.29%	10,972 $2.54 Million
Q1 2024 May 15, 2024	SELL	$212.02 - $267.71 $124,879 - $157,681	-589 Reduced 5.08%	11,004 $2.37 Million
Q4 2023 Feb 08, 2024	SELL	$222.59 - $267.94 $101,278 - $121,912	-455 Reduced 3.78%	11,593 $3 Million
Q3 2023 Oct 12, 2023	BUY	$253.3 - $285.89 $103,853 - $117,214	410 Added 3.52%	12,048 $3.1 Million
Q2 2023 Aug 07, 2023	BUY	$275.25 - $318.06 $69,363 - $80,151	252 Added 2.21%	11,638 $3.32 Million
Q1 2023 May 10, 2023	SELL	$256.56 - $292.34 $5,900 - $6,723	-23 Reduced 0.2%	11,386 $3.17 Million
Q4 2022 Feb 06, 2023	BUY	$252.44 - $306.72 $12,622 - $15,336	50 Added 0.44%	11,409 $3.16 Million
Q3 2022 Nov 16, 2022	BUY	$194.69 - $268.46 $95,398 - $131,545	490 Added 4.51%	11,359 $3.03 Million
Q2 2022 Aug 08, 2022	BUY	$187.54 - $223.02 $282,435 - $335,868	1,506 Added 16.08%	10,869 $2.22 Million
Q1 2022 May 09, 2022	BUY	$193.77 - $244.14 $101,535 - $127,929	524 Added 5.93%	9,363 $1.97 Million
Q4 2021 Feb 04, 2022	BUY	$223.92 - $287.77 $31,124 - $40,000	139 Added 1.6%	8,839 $2.12 Million
Q3 2021 Nov 17, 2021	SELL	$282.99 - $369.05 $18,960 - $24,726	-67 Reduced 0.76%	8,700 $2.46 Million
Q2 2021 Aug 12, 2021	SELL	$259.0 - $414.71 $110,852 - $177,495	-428 Reduced 4.65%	8,767 $3.04 Million
Q1 2021 May 14, 2021	SELL	$242.95 - $284.63 $14,577 - $17,077	-60 Reduced 0.65%	9,195 $2.57 Million
Q4 2020 Feb 11, 2021	BUY	$236.26 - $355.63 $1,417 - $2,133	6 Added 0.06%	9,255 $2.27 Million
Q3 2020 Nov 12, 2020	BUY	$264.77 - $305.71 $43,422 - $50,136	164 Added 1.81%	9,249 $2.62 Million
Q2 2020 Aug 12, 2020	SELL	$258.66 - $342.55 $837,541 - $1.11 Million	-3,238 Reduced 26.28%	9,085 $2.43 Million
Q1 2020 May 01, 2020	BUY	$268.85 - $341.04 $817,304 - $1.04 Million	3,040 Added 32.75%	12,323 $3.9 Million
Q4 2019 Feb 18, 2020	SELL	$220.06 - $304.07 $36,970 - $51,083	-168 Reduced 1.78%	9,283 $2.76 Million
Q3 2019 Nov 05, 2019	BUY	$217.44 - $243.88 $91,542 - $102,673	421 Added 4.66%	9,451 $2.2 Million
Q2 2019 Aug 07, 2019	BUY	$219.29 - $241.72 $94,294 - $103,939	430 Added 5.0%	9,030 $2.11 Million
Q1 2019 May 22, 2019	SELL	$216.71 - $338.96 $35,540 - $55,589	-164 Reduced 1.87%	8,600 $2.03 Million
Q4 2018 Feb 25, 2019	BUY	$278.5 - $352.75 $51,801 - $65,611	186 Added 2.17%	8,764 $2.64 Million
Q3 2018 Nov 19, 2018	SELL	$293.51 - $383.83 $3.21 Million - $4.19 Million	-10,924 Reduced 56.01%	8,578 $0
Q3 2018 Nov 16, 2018	BUY	$293.51 - $383.83 $3.09 Million - $4.05 Million	10,543 Added 117.68%	19,502 $0
Q2 2018 Aug 13, 2018	SELL	$257.52 - $306.91 $536,156 - $638,986	-2,082 Reduced 18.86%	8,959 $2.6 Million
Q1 2018 May 07, 2018	SELL	$260.13 - $367.91 $519,479 - $734,716	-1,997 Reduced 15.32%	11,041 $3.02 Million
Q4 2017 Feb 13, 2018	SELL	$307.64 - $344.58 $23,995 - $26,877	-78 Reduced 0.59%	13,038 $4.15 Million
Q3 2017 Nov 08, 2017	SELL	$281.15 - $329.69 $162,504 - $190,560	-578 Reduced 4.22%	13,116 $4.11 Million
Q2 2017 Aug 18, 2017	BUY	N/A	13,694	13,694 $3.72 Million

Others Institutions Holding BIIB

# of Institutions

1,018

Shares Held

128M

Call Options Held

1.22M

Put Options Held

1.4M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Kentucky Retirement Systems, based on Form 13F filings with the SEC.

News

Stay updated on Kentucky Retirement Systems with notifications on news.

Account

Kentucky Retirement Systems Biogen Inc. Transaction History